EMEIS Company Analysis & Research
EMEIS is the European leader in global dependency care, operating retirement homes, follow-up care clinics, and psychiatric clinics. The company, formerly known as Orpea and founded in 1989, is a French group that operates 1,051 establishments across more than 20 countries, serving vulnerable populations across Europe, Asia, and Latin America.
In February 2026, Emeis exited its accelerated safeguard plan following tribunal approval, marking successful recovery after a major 2022-2023 governance crisis. The company is executing a strategy to refocus and reduce debt while becoming a mission-driven company with commitments to vulnerable populations, care profession recognition, local social cohesion, and planet-friendly care.
Company Overview
Founded: 1989. Headquarters: Puteaux, France. Revenue: $6.27B. Employees: 83,500. Market Cap: $2.78B. Ticker: EMEIS (EURONEXT).
Industry
Senior Care & Dependent Healthcare Services
Cyborg Score: 6/10 — Solid
Restructured European care operator exiting financial distress with mission-driven strategy, but navigating lasting reputational headwinds and regulatory scrutiny.
Successful exit from court-supervised safeguard through significant asset sales and recapitalization demonstrates operational stability post-restructuring. However, the company continues facing multiple criminal procedures from 2022 violence revelations, and legacy reputational damage persists despite recent governance reforms.
Key Strategic Insights for EMEIS
- In France, EMEIS is leader of the private EHPAD (nursing home) market ahead of competitor Korian.
- Successfully exited accelerated safeguard plan in February 2026 through strategic asset sales and CDC-led recapitalization.
- In October 2025, finalized sale of independent senior residences business for €159 million, with potential €41.5M earnout, as part of debt reduction strategy.
- Global workforce of 83,500 professionals serving across 1,000+ facilities in 20+ countries.
Recent Developments
- (February 2026) Exited accelerated safeguard plan following tribunal approval in Nanterre
- (October 2025) Sold independent senior residences business for €159M (plus potential €41.5M earnout)
- (June 2025) Became mission-driven company with four governance commitments
Competitors & Competitive Landscape
- Korian — European care and senior housing operator
- Clariane — French post-acute care specialist
- Barchester Healthcare — UK-based independent care homes operator
EMEIS is the market leader for private nursing homes in France, ahead of competitor Korian. Primary competitors include Clariane, Korian Deutschland, Barchester Healthcare, Care UK, and Signature HealthCARE. The sector faces consolidation pressure and heightened regulatory scrutiny around care quality following industry-wide scandals.
More Company Research
National Gas Company SAOG Grand Twins International (Cambodia) Plc. PT Nusantara Pelabuhan Handal Tbk CLS Holdings plc Absci Corporation Oil-Dri Corporation Of America Immatics N.V. Iluka Resources Limited Madison Square Garden Entertainment Corp. Man Group plc HASEKO Corporation MBME GROUP Private Joint Stock Company Union Bank of India Limited Hewlett Packard Enterprise Company Arm Holdings plcFull Company Research Reports
Looking for a more in-depth analysis of EMEIS? AskCyborg's Company Research section contains full AI-generated reports with detailed financials, strategic analysis, and Cyborg Score ratings. Browse the complete company research library or explore industry research reports.
AskCyborg provides AI-powered company research and analysis. Visit AskCyborg for full reports, Cyborg Score ratings, and analyst podcasts.